1417564-98-7

Upstream product

• 215790-29-7 1,1-dimethylethyl[trans-4-(2-oxoethyl)cyclohexyl]carbamate 
• 105684-23-9 1-(benzo[d][1,3]dioxol-4-yl)piperazine hydrochloride 

Downstream Products

• 1394036-61-3 2,2,2-trifluoroethanesulfonic acid trans-N-{4-[2-(4-benzo[1,3]dioxol-4-ylpiperazin-1-yl)ethyl]cyclohexyl}amide 
• 1394036-65-7 N-trans-{4-[2-(4-benzo[1,3]dioxol-4-ylpiperazin-1-yl)ethyl]cyclohexyl}-2,2,2-trifluoroacetamide 
• 1394036-68-0 N-trans-{4-[2-(4-benzo[1,3]dioxol-4-ylpiperazin-1-yl)ethyl]cyclohexyl}-2-fluoroacetamide 
• 1394036-70-4 N-trans-1{4-[2-(4-benzo[1,3]dioxol-4-ylpiperazin-1-yl)ethyl]cyclohexyl}-3-(4-chlorophenyl)urea 
• 1394036-71-5 N-trans-{4-[2-(4-benzo[1,3]dioxol-4-ylpiperazin-1-yl)ethyl]cyclohexyl}-N,N-dimethylsulfamide 
• 1394036-07-7 trans-{4-[2-(4-benzo[1,3]dioxol-4-ylpiperazin-1-yl)ethyl]cyclohexyl}carbamic acid methyl ester 

Relevant academic research and scientific papers

NOVEL BENZODIOXOLE PIPERAZINE COMPOUNDS

The present invention is concerned with novel dual modulators of the 5-HT2A and D3 receptors of formula (I) wherein n, Y, R1, R2, R3, and R4 are as described herein, as well as pharmaceutically acceptable salts and esters thereof. Further the present invention is concerned with the manufacture of the compounds of formula (I), pharmaceutical compositions containing them and their use as pharmaceutical agents.